Please login to the form below

Not currently logged in
Email:
Password:

Intas Pharma

This page shows the latest Intas Pharma news and features for those working in and with pharma, biotech and healthcare.

Teva sells UK and Ireland assets to Intas Pharma for £603m

Teva sells UK and Ireland assets to Intas Pharma for £603m

Teva sells UK and Ireland assets to Intas Pharma for £603m. ... Accord will claim ownership of a portfolio of generic drugs as well as a manufacturing facility in Barnstaple, which will become privately-held Intas' fourth UK site.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch - May 2017 Deal Watch - May 2017

    Innocoll (pharma). 209. Capital International. Minority share. Intas (pharma). 106. Bain and others. ... Fingers crossed. Licensing by big pharma. The most common licensing deal is big pharma licensing in from biotech.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics